Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Completed · Phase 2

Conditions studied: Actinic Keratosis

In brief

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.

Key facts

Study ID
NCT00375739
Run by
Peplin
People needed
200
Starts
2006-09-01
Expected to finish
2007-06-01
Last updated by the study team
2016-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.